Home
All Journals
Expert Review of Gastroenterology & Hepatology
List of Issues
Volume 9, Issue sup1

Expert Review of Gastroenterology & Hepatology

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Review of Gastroenterology & Hepatology, Volume 9, Issue sup1 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Gastroenterology & Hepatology, Volume 9, Issue sup1 (2015)

See all volumes and issues

Vol 18, 2024 Vol 17, 2023 Vol 16, 2022 Vol 15, 2021 Vol 14, 2020 Vol 13, 2019 Vol 12, 2018 Vol 11, 2017 Vol 10, 2016 Volume 9, 2015 Vol 8, 2014 Vol 7, 2013 Vol 6, 2012 Vol 5, 2011 Vol 4, 2010 Vol 3, 2009 Vol 2, 2008 Vol 1, 2007

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Biosimilars for anti-TNF therapy: a case study of the first infliximab biosimilar, CT-P13

Editorial

An update on biosimilar drugs for inflammatory bowel disease

Stefan Schreiber

Pages: 1-3

Published online: 22 Sep 2015

AbstractforAn update on biosimilar drugs for inflammatory bowel disease | Full Text | References | PDF (249.5 KB)

2633 Views
4 CrossRef citations
0Altmetric

Free Access

Review

Stefan Schreiber, Julian Panés, ByoungOh Kwon, SeungSuh Hong & Laurent Peyrin-Biroulet

Pages: 5-15

Published online: 22 Sep 2015

AbstractforBiosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13 | Full Text | References | PDF (504.5 KB)

2857 Views
5 CrossRef citations
0Altmetric

Free Access

The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13

Walter Reinisch, Edouard Louis & Silvio Danese

Pages: 17-26

Published online: 22 Sep 2015

AbstractforThe scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13 | Full Text | References | PDF (1.1 MB)

2957 Views
16 CrossRef citations
0Altmetric

Free Access

The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?

Shomron Ben-Horin, Graham A Heap, Tariq Ahmad, HoUng Kim, TaekSang Kwon & Yehuda Chowers

Pages: 27-34

Published online: 22 Sep 2015

AbstractforThe immunogenicity of biosimilar infliximab: can we extrapolate the data across indications? | Full Text | References | PDF (451.9 KB)

7161 Views
35 CrossRef citations
0Altmetric

Free Access

Clinical Trial Report

Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea

Sang Hyoung Park, Young-Ho Kim, Ji Hyun Lee, Hyeok Jin Kwon, Suck-Ho Lee, Dong Il Park, Hyung Kil Kim, Jae Hee Cheon, Jong Pil Im, You Sun Kim, Sung Young Lee & Sang Joon Lee

Pages: 35-44

Published online: 22 Sep 2015

AbstractforPost-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea | Full Text | References | PDF (460.7 KB)

6915 Views
90 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Jørgen Jahnsen, Trond Espen Detlie, Simen Vatn & Petr Ricanek

Pages: 45-52

Published online: 22 Sep 2015

AbstractforBiosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study | Full Text | References | PDF (440.1 KB)

4793 Views
86 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages

Srikanth Iyer et al.

Review Article | Published online: 18 May 2024

Mistakes in utilising histopathology for the management of liver disease

Madunil Anuk Niriella et al.

Report | Published online: 15 May 2024

What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?

Irena Stefanova et al.

Report | Published online: 10 May 2024

Effectiveness of the pharmacological therapy to prevent post ERCP acute pancreatitis: a network meta-analysis

Edgar Julián Rojas-Victoria et al.

Review Article | Published online: 9 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Gastroenterology & Hepatology (Vol.9, Iss.sup1, 2015)

Biosimilars for anti-TNF therapy: a case study of the first infliximab biosimilar, CT-P13

Biosimilars for anti-TNF therapy: a case study of the first infliximab biosimilar, CT-P13

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?